Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|June 19, 2004
Dissociated glucocorticoid receptor ligandsHeike Schäcke, Hartmut RehwinkelCurrent Opinion in Investigational Drugs (London, England : 2000)|May 26, 2005
Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic indexHeike Schäcke, Hartmut Rehwinkel, Khusru AsadullahMolecular and Cellular Endocrinology|July 17, 2007
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexHeike Schäcke, Markus Berger, Hartmut Rehwinkel, et al.Experimental Dermatology|July 18, 2006
Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic indexHeike Schäcke, Hartmut Rehwinkel, Khusru Asadullah, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Dihydroquinolines as novel n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.Chemmedchem|August 24, 2016
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876Holger Siebeneicher, Arwed Cleve, Hartmut Rehwinkel, et al.Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Discovery of quinolines as selective glucocorticoid receptor agonistsStefan Jaroch, Markus Berger, Christoph Huwe, et al.Bioorganic & Medicinal Chemistry Letters|January 4, 2017
Discovery of new selective glucocorticoid receptor agonist leadsMarkus Berger, Hartmut Rehwinkel, Norbert Schmees, et al.Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidateMarkus Berger, Ekkehard May, Hartmut Rehwinkel, et al.Pageof 2